Search

Your search keyword '"Brandt, Alexander"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Brandt, Alexander" Remove constraint Author: "Brandt, Alexander" Topic 111702 aged health care Remove constraint Topic: 111702 aged health care
41 results on '"Brandt, Alexander"'

Search Results

1. sj-docx-11-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

2. sj-pdf-2-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

3. sj-docx-13-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

4. sj-docx-12-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

5. sj-docx-17-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

6. sj-docx-18-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

7. sj-docx-19-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

8. sj-docx-16-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

9. sj-docx-9-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

10. sj-docx-12-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

11. sj-docx-17-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

12. sj-pdf-3-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

13. sj-docx-8-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

14. sj-docx-14-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

15. sj-docx-8-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

16. sj-docx-15-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

17. sj-docx-18-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

18. sj-docx-19-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

19. sj-docx-11-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

20. sj-pdf-1-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

21. sj-docx-9-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

22. sj-pdf-2-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

23. sj-pdf-1-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

24. sj-docx-15-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

25. sj-pdf-4-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

26. sj-docx-16-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

27. sj-docx-10-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

28. sj-pdf-3-msj-10.1177_13524585221097296 – Supplemental material for Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis

29. sj-pdf-2-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders

30. sj-pdf-1-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders

31. sj-pdf-2-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders

32. sj-pdf-4-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders

33. sj-pdf-3-msj-10.1177_13524585211003479 – Supplemental material for Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation

34. sj-pdf-1-msj-10.1177_13524585211003479 – Supplemental material for Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation

35. sj-pdf-4-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders

36. sj-pdf-2-msj-10.1177_13524585211003479 – Supplemental material for Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation

37. sj-pdf-1-msj-10.1177_13524585211003479 – Supplemental material for Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation

38. sj-pdf-1-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders

39. sj-pdf-3-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders

40. sj-pdf-3-msj-10.1177_13524585211032801 – Supplemental material for Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders

41. sj-pdf-3-msj-10.1177_13524585211003479 – Supplemental material for Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation

Catalog

Books, media, physical & digital resources